Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
<p>Abstract</p> <p>Background</p> <p>Many studies have investigated the efficacy of Endostar combined with platinum-based doublet chemotherapy (PBDC) versus PBDC alone for treating advanced non-small cell lung cancer (NSCLC). This study is a meta-analysis of available e...
Main Authors: | Biaoxue Rong, Shuanying Yang, Wei Li, Wei Zhang, Zongjuan Ming |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://www.wjso.com/content/10/1/170 |
Similar Items
-
Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis
by: Li Feng, et al.
Published: (2021-02-01) -
The Comparison of Clinical Effect of Rh-endostar on Retreated Non-Small Cell Lung Cancer and Colorectal Cancer
by: Xueqin YANG, et al.
Published: (2009-11-01) -
Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies
by: Bo Wang, et al.
Published: (2020-10-01) -
Mechanism of Shenyi Capsule Concomitant with Endostar and Chemotherapy on the Growth and Apoptosis of MCF-7 Breast Cancer Cells
by: Mingwen Shao, et al.
Published: (2014-06-01) -
Efficacy and Safety of rh-Endostatin Combined with Chemotherapy
versus Chemotherapy Alone for Advanced NSCLC: A Meta-analysis Review
by: Jinzhong ZHANG, et al.
Published: (2011-05-01)